2004•Inpharma WeeklyRequires access
Treatment with atomoxetine may have limited value in children with attention-deficit hyperactivity disorder (ADHD) who do not respond to stimulants,
&NA;
Open publisher page 0 citations
Abstract
This record does not include an abstract. Use the full-text link above if available.